Anticipated news over next 12 months ..hope so, particularly daptomyacin and propofol
Initial cannabinoid formulation development with TPM®
Preclinical studies evaluating TPM® cannabinoids
First-in-man studies using TPM®-formulated cannabinoids
Disease-specific clinical trials using TPM®-cannabinoids
Commercial licence or sale of one or more human health assets23 June 2020
Ann: Avecho Investor Update, page-5
-
- There are more pages in this discussion • 72 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(20.0%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $33 | 10.94K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 62 | 99962608 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 53831289 | 11 |
View Market Depth
| Last trade - 13.14pm 17/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |